Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release by the company (together with its subsidiaries / associate companies, ‘Sun Pharma’) and Israel-based Moebius Medical about the announcement of publication of two articles in Osteoarthritis and Cartilage, the official journal of the Osteoarthritis Research Society International (OARSI), highlighting MM-II, a novel nonopioid product for the treatment of symptomatic knee osteoarthritis.
The above information is a part of company’s filings submitted to BSE.
